| Jay T Peterson Sr, MD | |
|
6429 High Dr, Mission Hills, KS 66208-1935 | |
| (913) 722-5825 | |
| Not Available |
| Full Name | Jay T Peterson Sr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 6429 High Dr, Mission Hills, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376515726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04-14230 (Kansas) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | R6888 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jay T Peterson Sr, MD 6429 High Dr, Mission Hills, KS 66208-1935 Ph: (913) 722-5825 | Jay T Peterson Sr, MD 6429 High Dr, Mission Hills, KS 66208-1935 Ph: (913) 722-5825 |
News Archive
Ann Clock Eddins, Ph.D., director of Audiology at the University of Rochester Medical Center, will present a free talk from 4 to 5:30 p.m. Tuesday, April 28, at the Hahnemann Club, 201 Stoutenberg Lane, located on the campus of The Highlands at Pittsford (off of Rt. 31, just east of the village of Pittsford).
A research group at the Department of Microbiology, Swedish University of Agricultural Sciences (SLU) in Uppsala, Sweden has - in collaboration with J-I Flock's research group at the Karolinska Institutet medical university in Stockholm, the pharmacological company Intervacc AB, Stockholm and the Animal Health Trust in the UK - after many years of research made a breakthrough in finding a vaccine against the horse disease strangle.
ChemDiv Inc. of San Diego, and iDialog (Intellektualniy Dialog) of Yaroslavl, Russia, announced today the successful completion of a pre-clinical development and the subsequent nomination of ID-12 as lead clinical development candidate for the treatment of chronic hepatitis C. This novel small molecule orally-bioavailable inhibitor of hepatitis C virus (HCV) blocks early stage of viral infection.
Star Scientific, Inc. announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDL™ as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
Leading post-production house Optimus Santa Monica today announced that the "Fight 2 Win" PSA – created by Draftfcb Irvine Creative Director Scott Murray, produced by Draftfcb Irvine Senior Producer Tom Anderson, directed by RSA's Russo Brothers and edited by Optimus Santa Monica Editor Hovig Menakian– has launched and will run through the end of 2009 on Fox, Turner and ESPN.
› Verified 8 days ago
Michelle E Oza, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6701 High Dr, Mission Hills, KS 66208 Phone: 816-519-5447 | |
Dr. John Kennedy Layle Jr., MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5800 High Dr, Mission Hills, KS 66208 Phone: 913-432-2009 | |
Dr. Daniel L Schlozman, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6600 Overhill Rd, Mission Hills, KS 66208 Phone: 913-677-0019 |